A new device to quickly diagnose early sepsis using blood samples
Point-of-Care Microfluidic Biochip for Biomarkers Monitoring for Contributing in Early Sepsis Diagnosis
This study is working on a small device that quickly checks blood samples for signs of early sepsis, helping doctors diagnose and treat this serious condition faster to improve patient care and outcomes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10892161 on NIH RePORTER |
What this research studies
This research focuses on developing a microfluidic biochip that can rapidly analyze blood samples to detect biomarkers associated with early sepsis. By providing timely and accurate diagnoses, the device aims to improve patient outcomes by enabling healthcare providers to initiate treatment sooner. The approach involves using advanced technology to monitor specific biological markers that indicate the presence of sepsis, which is often misdiagnosed due to non-specific symptoms. The goal is to reduce mortality rates and hospital readmissions associated with this life-threatening condition.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 years old who are at risk of developing sepsis, particularly those presenting with symptoms in emergency or intensive care settings.
Not a fit: Patients who are not at risk for sepsis or those who are already diagnosed with severe sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve early detection and treatment of sepsis, potentially saving lives and reducing healthcare costs.
How similar studies have performed: Other research has shown promise in using advanced diagnostic technologies for sepsis detection, indicating that this approach could lead to significant advancements in patient care.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Bashir, Rashid — University of Illinois at Urbana-Champaign
- Study coordinator: Bashir, Rashid
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.